Corrigendum: Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells (Oncogene (2010) 30 (1302-1317) DOI: 10.1038/onc.2010.512);Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells

Oncogene

Volumn 30, Issue 11, 2011, Pages 1302-1317

  Prazeres, H ^a,b,c   Torres, J ^a   Rodrigues, F ^c   Pinto, M ^a   Pastoriza, M C ^d   Gomes, D ^c   Cameselle Teijeiro, J ^e   Vidal, A ^d   Martins, T C ^c   Sobrinho Simoes M ^a,b   Soares, P ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c Instituto Portugues de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra SA   (Portugal)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e Instituto de Salud Carlos III   (Spain)

Author keywords

endocytosis and tumor microenvironment; EP300 histone acetyltransferase; low density lipoprotein receptor family; matrix metalloproteinase 2; microRNA; tumor suppressor gene

Indexed keywords

HISTONE ACETYLTRANSFERASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MATRIX METALLOPROTEINASE; MICRORNA;

ANIMAL CELL; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CHROMOSOME; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EMBRYO; ENDOSOME; EPIGENETICS; EXTRACELLULAR MATRIX; GENE DOSAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRON; NONHUMAN; PRIORITY JOURNAL; THYROID CANCER; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

EID: 79952775150     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.143     Document Type: Erratum

References (55)

1. Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R. (1995). A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374: 81-84.
2. Asami Y, Mori M, Koshino H, Sekiyama Y, Teruya T, Simizu S et al. (2009). A cell-based screening to detect inhibitors of BRAF signaling pathway. J Antibiot (Tokyo) 62: 105-107.
3. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J et al. (2010). The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
4. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P et al. (1997). Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61: 1123-1130. (Pubitemid 27492321)
5. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J et al. (1998). A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63: 1743-1748. (Pubitemid 30415737)
6. Cavaco BM, Batista PF, Sobrinho LG, Leite V. (2008). Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density snp genome-wide linkage analysis. J Clin Endocrinol Metab 93: 4426-4430. (Pubitemid 352789543)
7. Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, Thorne NP et al. (2007). High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8: R215.
8. Clark SJ, Harrison J, Frommer M. (1995). CpNpG methylation in mammalian cells. Nat Genet 10: 20-27.
9. Dedieu S, Langlois B, Devy J, Sid B, Henriet P, Sartelet H et al. (2008). LRP-1 silencing prevents malignant cell invasion despite increased pericellular proteolytic activities. Mol Cell Biol 28: 2980-2995. (Pubitemid 351556530)
10. Desrosiers RR, Rivard ME, Grundy PE, Annabi B. (2006). Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors. Pediatr Blood Cancer 46: 40-49. (Pubitemid 41779316)
11. Emonard H, Bellon G, de Diesbach P, Mettlen M, Hornebeck W, Courtoy PJ. (2005). Regulation of matrix metalloproteinase (MMP) activity by the low-density lipoprotein receptor-related protein (LRP). A new function for an 'old friend'. Biochimie 87: 369-376. (Pubitemid 40387616)
12. Emonard H, Bellon G, Troeberg L, Berton A, Robinet A, Henriet P et al. (2004). Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism. J Biol Chem 279: 54944-54951. (Pubitemid 40053241)
13. Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF et al. (2000). Mutations truncating the EP300 acetylase in human cancers. Nat Genet 24: 300-303. (Pubitemid 30132203)
14. Gustafsdottir SM, Schlingemann J, Rada-Iglesias A, Schallmeiner E, Kamali-Moghaddam M, Wadelius C et al. (2007). In vitro analysis of DNA-protein interactions by proximity ligation. Proc Natl Acad Sci USA 104: 3067-3072. (Pubitemid 46364114)
15. Hagedorn M, Javerzat S, Gilges D, Meyre A, de Lafarge B, Eichmann A et al. (2005). Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci USA 102: 1643-1648. (Pubitemid 40209221)
16. Hahn-Dantona E, Ruiz JF, Bornstein P, Strickland DK. (2001). The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J Biol Chem 276: 15498-15503.
17. He H, Nagy R, Liyanarachchi S, Jiao H, Li W, Suster S et al. (2009). A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69: 625-631.
18. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. (1998). Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367. (Pubitemid 28295292)
19. Herz J, Clouthier DE, Hammer RE. (1992). LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71: 411-421.
20. Herz J, Strickland DK. (2001). LRP: a multifunctional scavenger and signaling receptor. J Clin Invest 108: 779-784. (Pubitemid 32880284)
21. Horlings HM, Lai C, Nuyten DS, Halfwerk H, Kristel P, van Beers E et al. (2010). Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients. Clin Cancer Res 16: 651-663.
22. Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M et al. (1997). Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90: 4699-4704. (Pubitemid 28007181)
23. Knisely JM, Li Y, Griffith JM, Geuze HJ, Schwartz AL, Bu G. (2007). Slow endocytosis of the LDL receptor-related protein 1B: implications for a novel cytoplasmic tail conformation. Exp Cell Res 313: 3298-3307. (Pubitemid 47284064)
24. Kohno T, Otsuka A, Girard L, Sato M, Iwakawa R, Ogiwara H et al. (2010). A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes Cancer 49: 342-352.
25. Li Y, Knisely JM, Lu W, McCormick LM, Wang J, Henkin J et al. (2002). Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration. J Biol Chem 277: 42366-42371. (Pubitemid 35257558)
26. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J et al. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315-322.
27. Liu CX, Li Y, Obermoeller-McCormick LM, Schwartz AL, Bu G. (2001). The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein. J Biol Chem 276: 28889-28896.
28. Liu CX, Musco S, Lisitsina NM, Forgacs E, Minna JD, Lisitsyn NA. (2000a). LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines. Cancer Res 60: 1961-1967. (Pubitemid 30207658)
29. Liu CX, Musco S, Lisitsina NM, Yaklichkin SY, Lisitsyn NA. (2000b). Genomic organization of a new candidate tumor suppressor gene, LRP1B. Genomics 69: 271-274.
30. Liu CX, Ranganathan S, Robinson S, Strickland DK. (2007). gamma-Secretase-mediated release of the low density lipoprotein receptor-related protein 1B intracellular domain suppresses anchorage-independent growth of neuroglioma cells. J Biol Chem 282: 7504-7511. (Pubitemid 47093695)
31. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V et al. (2000). Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85: 1758-1764. (Pubitemid 32269272)
32. Malone CS, Miner MD, Doerr JR, Jackson JP, Jacobsen SE, Wall R et al. (2001). CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing. Proc Natl Acad Sci USA 98: 10404-10409. (Pubitemid 32803032)
33. Marschang P, Brich J, Weeber EJ, Sweatt JD, Shelton JM, Richardson JA et al. (2004). Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1. Mol Cell Biol 24: 3782-3793. (Pubitemid 38496157)
34. Mateus AR, Simoes-Correia J, Figueiredo J, Heindl S, Alves CC, Suriano G et al. (2009). E-cadherin mutations and cell motility: a genotype-phenotype correlation. Exp Cell Res 315: 1393-1402.
35. May P, Woldt E, Matz RL, Boucher P. (2007). The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med 39: 219-228. (Pubitemid 46676481)
36. McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L et al. (2001). Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69: 440-446. (Pubitemid 32695216)
37. Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM et al. (1996). p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12: 1565-1569. (Pubitemid 26132043)
38. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A et al. (2008). Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68: 5795-5802.
39. Nykjaer A, Petersen CM, Moller B, Jensen PH, Moestrup SK, Holtet TL et al. (1992). Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J Biol Chem 267: 14543-14546.
40. Prazeres HJ, Rodrigues F, Soares P, Naidenov P, Figueiredo P, Campos B et al. (2008). Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam Cancer 7: 141-149. (Pubitemid 351871906)
41. Ribeiro AS, Albergaria A, Sousa B, Correia AL, Bracke M, Seruca R et al. (2010). Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 29: 392-402.
42. Ribeiro FR, Meireles AM, Rocha AS, Teixeira MR. (2008). Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples. BMC Cancer 8: 371.
43. Rikitake Y, Moran E. (1992). DNA-binding properties of the E1A-associated 300-kilodalton protein. Mol Cell Biol 12: 2826-2836.
44. Roy R, Yang J, Moses MA. (2009). Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27: 5287-5297.
45. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA et al. (2008). Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93: 4331-4341. (Pubitemid 352789529)
46. Shiroshima T, Oka C, Kawaichi M. (2009). Identification of LRP1B-interacting proteins and inhibition of protein kinase Calpha- phosphorylation of LRP1B by association with PICK1. FEBS Lett 583: 43-48.
47. Song H, Li Y, Lee J, Schwartz AL, Bu G. (2009). Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metallopro-teinases 2 and 9. Cancer Res 69: 879-886.
48. Stankov K, Pastore A, Toschi L, McKay J, Lesueur F, Kraimps JL et al. (2004). Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors. Int J Cancer 111: 463-467. (Pubitemid 38998831)
49. Suh I, Filetti S, Vriens MR, Guerrero MA, Tumino S, Wong M et al. (2009). Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families. Surgery 146: 1073-1080.
50. Tanaga K, Bujo H, Zhu Y, Kanaki T, Hirayama S, Takahashi K et al. (2004). LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors. Arterioscler Thromb Vasc Biol 24: 1422-1428. (Pubitemid 39050435)
51. Toth M, Muller U, Doerfler W. (1990). Establishment of de novo DNA methylation patterns. Transcription factor binding and deoxycytidine methylation at CpG and non-CpG sequences in an integrated adenovirus promoter. J Mol Biol 214: 673-683.
52. 0Armiento M. (2009). The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets 9: 32-71.
53. Walker LC, Harris GC, Wells JE, Robinson BA, Morris CM. (2008). Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies. Genes Chromosomes Cancer 47: 405-417. (Pubitemid 351451795)
54. Woodcock DM, Lawler CB, Linsenmeyer ME, Doherty JP, Warren WD. (1997). Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon. J Biol Chem 272: 7810-7816. (Pubitemid 27137338)
55. Yang Z, Strickland DK, Bornstein P. (2001). Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J Biol Chem 276: 8403-8408.